PDCD1 and neoplasm: They found that the expression of KLHL22 was markedly decreased in tumor-infiltrating T cells from colorectal cancer patients and suggested the therapeutic potential of 5-FU (which could increase PD-1 expression by inhibiting the transcription of KLHL22) in combination with anti-PD-1 in colorectal cancer patients (19).